Your search returned 688 results.

Results
	521.	Cell surface expression of CCR5 and other host factors influence the inhibition of HIV-1 infection of human lymphocytes by CCR5 ligands. [electronic resource] by Ketas, Thomas J Kuhmann, Shawn E Palmer, Ashley Zurita, Juan He, Weijing Ahuja, Sunil K Klasse, Per Johan Moore, John P Producer: 20070801 In: Virology vol. 364 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	522.	Effect of maraviroc on the pharmacokinetics of midazolam, lamivudine/zidovudine, and ethinyloestradiol/levonorgestrel in healthy volunteers. [electronic resource] by Abel, Samantha Russell, Deborah Whitlock, Lyndsey A Ridgway, Caroline E Muirhead, Gary J Producer: 20080723 In: British journal of clinical pharmacology vol. 65 Suppl 1 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	523.	Protection of rhesus macaques from vaginal infection by vaginally delivered maraviroc, an inhibitor of HIV-1 entry via the CCR5 co-receptor. [electronic resource] by Veazey, Ronald S Ketas, Thomas J Dufour, Jason Moroney-Rasmussen, Terri Green, Linda C Klasse, P J Moore, John P Producer: 20100902 In: The Journal of infectious diseases vol. 202 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	524.	Mutations in gp41 are correlated with coreceptor tropism but do not improve prediction methods substantially. [electronic resource] by Thielen, Alexander Lengauer, Thomas Swenson, Luke C Dong, Winnie W Y McGovern, Rachel A Lewis, Marilyn James, Ian Heera, Jayvant Valdez, Hernan Harrigan, P Richard Producer: 20110906 In: Antiviral therapy vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	525.	Responses to switching to maraviroc-based antiretroviral therapy in treated patients with suppressed plasma HIV-1-RNA load. [electronic resource] by Vitiello, Paola Brudney, Daniel MacCartney, Malcolm Garcia, Ana Smith, Colette Marshall, Neal Johnson, Margaret Geretti, Anna Maria Producer: 20120516 In: Intervirology vol. 55 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	526.	Maraviroc improves hepatic triglyceride content but not inflammation in a murine nonalcoholic fatty liver disease model induced by a chronic exposure to high-fat diet. [electronic resource] by Pérez-Martínez, Laura Ochoa-Callejero, Laura Rubio-Mediavilla, Susana Narro, Judit Bernardo, Iván Oteo, José-Antonio Blanco, José-Ramón Producer: 20180823 In: Translational research : the journal of laboratory and clinical medicine vol. 196 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	527.	Maraviroc, a chemokine CCR5 receptor antagonist for the treatment of HIV infection and AIDS. [electronic resource] by Meanwell, Nicholas A Kadow, John F Producer: 20071127 In: Current opinion in investigational drugs (London, England : 2000) vol. 8 Availability: No items available. Save to lists Add to cart (remove)
	528.	T-cell changes after a short-term exposure to maraviroc in HIV-infected patients are related to antiviral activity. [electronic resource] by Pulido, Ildefonso Machmach, Kawthar Romero-Sánchez, María C Genebat, Miguel Mendez-Lagares, Gema Ruiz-Mateos, Ezequiel Leal, Manuel Producer: 20120710 In: The Journal of infection vol. 64 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	529.	Maraviroc intensification in patients with suppressed HIV viremia has limited effects on CD4+ T cell recovery and gene expression. [electronic resource] by Beliakova-Bethell, Nadejda Jain, Sonia Woelk, Christopher H Witt, Mallory D Sun, Xiaoying Lada, Steven M Spina, Celsa A Goicoechea, Miguel Rought, Steffney E Haubrich, Richard Dubé, Michael P Producer: 20150123 In: Antiviral research vol. 107 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	530.	Clinical outcome of maraviroc-containing therapy in heavily pre-treated HIV-1-infected patients. [electronic resource] by van Lelyveld, S F L Symons, J van Ham, P Connell, B J Nijhuis, M Wensing, A M J Hoepelman, A I M Producer: 20161017 In: International journal of antimicrobial agents vol. 47 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	531.	The effects of CCR5 inhibition on regulatory T-cell recruitment to colorectal cancer. [electronic resource] by Ward, S T Li, K K Hepburn, E Weston, C J Curbishley, S M Reynolds, G M Hejmadi, R K Bicknell, R Eksteen, B Ismail, T Rot, A Adams, D H Producer: 20150320 In: British journal of cancer vol. 112 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	532.	Adherence and Acceptability of a Multidrug Vaginal Ring for HIV Prevention in a Phase I Study in the United States. [electronic resource] by van der Straten, Ariane Panther, Lori Laborde, Nicole Hoesley, Craig J Cheng, Helen Husnik, Marla J Horn, Stephanie Nel, Annalene Soto-Torres, Lydia Chen, Beatrice A Producer: 20171226 In: AIDS and behavior vol. 20 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	533.	Reviews of anti-infective agents: maraviroc: the first of a new class of antiretroviral agents. [electronic resource] by MacArthur, Rodger D Novak, Richard M Producer: 20080909 In: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America vol. 47 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	534.	Glioblastoma: synergy of growth promotion between CCL5 and NK-1R can be thwarted by blocking CCL5 with miraviroc, an FDA approved anti-HIV drug and blocking NK-1R with aprepitant, an FDA approved anti-nausea drug. [electronic resource] by Kast, R E Producer: 20110517 In: Journal of clinical pharmacy and therapeutics vol. 35 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	535.	The immunologic effects of maraviroc intensification in treated HIV-infected individuals with incomplete CD4+ T-cell recovery: a randomized trial. [electronic resource] by Hunt, Peter W Shulman, Nancy S Hayes, Timothy L Dahl, Viktor Somsouk, Ma Funderburg, Nicholas T McLaughlin, Bridget Landay, Alan L Adeyemi, Oluwatoyin Gilman, Lee E Clagett, Brian Rodriguez, Benigno Martin, Jeffrey N Schacker, Timothy W Shacklett, Barbara L Palmer, Sarah Lederman, Michael M Deeks, Steven G Producer: 20130806 In: Blood vol. 121 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	536.	Effects of Therapy with Maraviroc on the Carotid Intima Media Thickness in HIV-1/HCV Co-infected Patients. [electronic resource] by Maggi, Paolo Bruno, Giuseppe Perilli, Francesco Saracino, Annalisa Volpe, Anna Santoro, Carmen Ladisa, Nicoletta Angarano, Gioacchino Producer: 20170425 In: In vivo (Athens, Greece) vol. 31 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	537.	96-Week MERIT ES analysis shows efficacy of Celsentri=Selzentry. [electronic resource] Producer: 20110922 In: AIDS patient care and STDs vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	538.	Modulatory effects of the CCR5 antagonist maraviroc on microglial pro-inflammatory activation elicited by gp120. [electronic resource] by Lisi, Lucia Tramutola, Antonella De Luca, Andrea Navarra, Pierluigi Dello Russo, Cinzia Producer: 20120206 In: Journal of neurochemistry vol. 120 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	539.	HIV-1 dynamics and coreceptor usage in Maraviroc-treated patients with ongoing replication. [electronic resource] by Recordon-Pinson, P Raymond, S Bellecave, P Marcelin, A G Soulie, C Descamps, D Calvez, V Harrigan, P R Fleury, H Izopet, J Masquelier, B Producer: 20130729 In: Antimicrobial agents and chemotherapy vol. 57 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	540.	Deep sequencing to infer HIV-1 co-receptor usage: application to three clinical trials of maraviroc in treatment-experienced patients. [electronic resource] by Swenson, Luke C Mo, Theresa Dong, Winnie W Y Zhong, Xiaoyin Woods, Conan K Jensen, Mark A Thielen, Alexander Chapman, Douglass Lewis, Marilyn James, Ian Heera, Jayvant Valdez, Hernan Harrigan, P Richard Producer: 20110314 In: The Journal of infectious diseases vol. 203 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

First
Previous
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 688 results.